Table 1

Clinical characteristics and laboratory profiles of patients with acquired aplastic anemia carrying SBDS gene mutations

PatientAge, ySexRace or ethnic groupHemoglobin, g/dLANC, /μLPlatelet count, 109/LBM cellularity, %Family historyCourse
19 Hispanic 6.2 300 10 10 Mother with mild anemia No response to immunosuppression; died after MUD BM transplantation 
White 6.9 600 12 10 No No response to immunosuppression; developed MDS, monosomy 7; died after MUD BM transplantation 
19 Black 3.3 400 Mother with mild anemia (Hb, 11 g/dL; MCV, 89 fL) Transient response to immunosuppression; responded to MR-PBSCT 
12 Black 200 20 < 5 Mother with mild anemia (Hb, 10.9 g/dL; MCV, 85 fL) No response to immunosuppression 
PatientAge, ySexRace or ethnic groupHemoglobin, g/dLANC, /μLPlatelet count, 109/LBM cellularity, %Family historyCourse
19 Hispanic 6.2 300 10 10 Mother with mild anemia No response to immunosuppression; died after MUD BM transplantation 
White 6.9 600 12 10 No No response to immunosuppression; developed MDS, monosomy 7; died after MUD BM transplantation 
19 Black 3.3 400 Mother with mild anemia (Hb, 11 g/dL; MCV, 89 fL) Transient response to immunosuppression; responded to MR-PBSCT 
12 Black 200 20 < 5 Mother with mild anemia (Hb, 10.9 g/dL; MCV, 85 fL) No response to immunosuppression 

ANC indicates absolute neutrophil count; BM, bone marrow; MUD, matched unrelated donor; MDS, myelodysplastic syndrome; MR-PBSCT, matched related peripheral blood stem cell transplantation.

or Create an Account

Close Modal
Close Modal